March 31, 2021
February 25, 2021
COVID-19 vaccination and patients with cancer; the impact of delayed screening; a virtual Spring 2021 Group Meeting
January 25, 2021
The co-chairs look ahead to the new year, and acknowledge key successes from 2020—despite its many challenges
December 14, 2020
Lessons learned from our first virtual Group Meeting and a new leadership appointment
October 20, 2020
What are the elements of a productive meeting when we get together – and what might they look like in a virtual format?
September 14, 2020
Welcome to the News From ECOG-ACRIN blog; COVID-19 month six reflections; clinical trial enrollment continues to improve; EA Cancer Research Advocates Committee adds five new members
July 29, 2020
In the fifth month of restrictions due to COVID-19, member institutions pivot back to focus on general health care; clinical trial enrollments begin to rise back up to pre-pandemic levels; Fall 2020 Group Meeting to be virtual; EA holds first meeting of planned move to an anti-racist agenda
June 10, 2020
Strong EA research presence at ASCO 2020; the horrific killing of George Floyd; health equity and diversity in the field of oncology; the need for EA to participate in changing a specifically anti-racist culture and increase diversity and inclusion
May 29, 2020
What we know about COVID-19; remembering Valerie Guild; spotlight on Indiana University's Melvin and Bren Simon Comprehensive Cancer Center
April 15, 2020
Seamless patient mangement during the pandemic; COVID-19 Virtual Town Hall for Community Physicians and Research Staff; remembering Dr. Uma Rao; recognizing the John H. Stroger, Jr. Hospital of Cook County Minority Underserved NCORP; spotlight on the EROS trial, which is evaluating a program to help women with cancer and their physicians plan for reproductive health and preservation of sexuality during and after cancer treatment
February 28, 2020
January meeting with NCI leaders and the Cooperative Group Chairs; Congress increases NCI and overall NIH budget for FY 2020; EA opens two new trials, one for pancreatic cyst monitoring (EA2185) and the other to evaluate nivolumab in head and neck cancer (EA3161); plans are underway for the next Comis Symposium
January 14, 2020
Reflecting on key milestones in 2019: TMIST breast cancer screening trial continues to ramp up; NCORP grant renewal emphasizes screening, symptom control, and cancer care delivery research; new role for Dr. Al Benson; E1912's practice-changing trial results; update on Dr. Otis Brawley's efforts to form the Social Determinants of Health Working Group; EA launches the Comis Symposium